37
https://pubmed.ncbi.nlm.nih.gov/38115126
The dual blockade of EGFR and PI3K signaling pathways with AZD-9291 and GDC-0084 shows promise as a therapeutic strategy for glioblastoma.
Dual blockade of EGFR and PI3K signaling pathways: a promising therapeutic strategy for glioblastoma using AZD-9291 and GDC-0084.
